These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1426 related articles for article (PubMed ID: 28045404)

  • 1. Liver inflammation and fibrosis.
    Koyama Y; Brenner DA
    J Clin Invest; 2017 Jan; 127(1):55-64. PubMed ID: 28045404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The innate immune receptor TREM-1 promotes liver injury and fibrosis.
    Nguyen-Lefebvre AT; Ajith A; Portik-Dobos V; Horuzsko DD; Arbab AS; Dzutsev A; Sadek R; Trinchieri G; Horuzsko A
    J Clin Invest; 2018 Nov; 128(11):4870-4883. PubMed ID: 30137027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease.
    Katsarou A; Moustakas II; Pyrina I; Lembessis P; Koutsilieris M; Chatzigeorgiou A
    World J Gastroenterol; 2020 May; 26(17):1993-2011. PubMed ID: 32536770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kupffer cells promote T-cell hepatitis by producing CXCL10 and limiting liver sinusoidal endothelial cell permeability.
    Dai S; Liu F; Qin Z; Zhang J; Chen J; Ding WX; Feng D; Ji Y; Qin X
    Theranostics; 2020; 10(16):7163-7177. PubMed ID: 32641985
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of Liver Inflammation and Fibrosis by Interleukin-37.
    Mountford S; Effenberger M; Noll-Puchta H; Griessmair L; Ringleb A; Haas S; Denk G; Reiter FP; Mayr D; Dinarello CA; Tilg H; Bufler P
    Front Immunol; 2021; 12():603649. PubMed ID: 33746950
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrophages: master regulators of inflammation and fibrosis.
    Wynn TA; Barron L
    Semin Liver Dis; 2010 Aug; 30(3):245-57. PubMed ID: 20665377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic Dendritic Cells in the Development and Progression of Metabolic Steatohepatitis.
    Méndez-Sánchez N; Córdova-Gallardo J; Barranco-Fragoso B; Eslam M
    Front Immunol; 2021; 12():641240. PubMed ID: 33833761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C.
    Tanwar S; Rhodes F; Srivastava A; Trembling PM; Rosenberg WM
    World J Gastroenterol; 2020 Jan; 26(2):109-133. PubMed ID: 31969775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Kupffer Cells in Driving Hepatic Inflammation and Fibrosis in HIV Infection.
    Zhang L; Bansal MB
    Front Immunol; 2020; 11():1086. PubMed ID: 32612603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation.
    Borkham-Kamphorst E; Drews F; Weiskirchen R
    Liver Int; 2011 May; 31(5):656-65. PubMed ID: 21457438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 4 and hepatic fibrogenesis.
    Pradere JP; Troeger JS; Dapito DH; Mencin AA; Schwabe RF
    Semin Liver Dis; 2010 Aug; 30(3):232-44. PubMed ID: 20665376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver fibrosis and repair: immune regulation of wound healing in a solid organ.
    Pellicoro A; Ramachandran P; Iredale JP; Fallowfield JA
    Nat Rev Immunol; 2014 Mar; 14(3):181-94. PubMed ID: 24566915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease.
    Vespasiani-Gentilucci U; Carotti S; Onetti-Muda A; Perrone G; Ginanni-Corradini S; Latasa MU; Avila MA; Carpino G; Picardi A; Morini S
    Mod Pathol; 2012 Apr; 25(4):576-89. PubMed ID: 22173288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer.
    Lurje I; Hammerich L; Tacke F
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.
    Karin D; Koyama Y; Brenner D; Kisseleva T
    Differentiation; 2016 Sep; 92(3):84-92. PubMed ID: 27591095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in researches on macrophages in liver fibrosis of schistosomiasis].
    Xie YY; Xu YH; Chu DY; Shen JL
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2015 Dec; 27(6):669-73. PubMed ID: 27097498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages in metabolic associated fatty liver disease.
    Alharthi J; Latchoumanin O; George J; Eslam M
    World J Gastroenterol; 2020 Apr; 26(16):1861-1878. PubMed ID: 32390698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis.
    Yang F; Li H; Li Y; Hao Y; Wang C; Jia P; Chen X; Ma S; Xiao Z
    Int Immunopharmacol; 2021 Oct; 99():108051. PubMed ID: 34426110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk network among multiple inflammatory mediators in liver fibrosis.
    Zhangdi HJ; Su SB; Wang F; Liang ZY; Yan YD; Qin SY; Jiang HX
    World J Gastroenterol; 2019 Sep; 25(33):4835-4849. PubMed ID: 31543677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocytes and macrophages as cellular targets in liver fibrosis.
    Heymann F; Trautwein C; Tacke F
    Inflamm Allergy Drug Targets; 2009 Sep; 8(4):307-18. PubMed ID: 19534673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.